Mirus Corp
Mirus Bio, based in Madison, WI, is a pioneering company that has been transforming the science of transfection since 1995. With a focus on intentional design, they have developed proven nucleic acid delivery systems for a wide range of applications, from viral vector manufacturing to protein production.
Their innovative technologies, such as the TransIT-VirusGEN Transfection Reagent, enable enhanced delivery of packaging and transfer plasmids, leading to increased production of recombinant adeno-associated virus (AAV) and lentivirus. Mirus Bio's dedication to overcoming challenges in viral vector optimization has resulted in groundbreaking gene therapies, with the potential to revolutionize the treatment of diseases like hemophilia.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.